Synopsys (SNPS) Financials

$425.45 -12.65 (-2.89%)

Closing price 09/12/2025 04:00 PM Eastern

Extended Trading

$425.79 +0.34 (+0.08%)

As of 09/12/2025 07:59 PM Eastern

Annual Income Statements for Synopsys

This table shows Synopsys' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	10/31/2014	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024
Net Income / (Loss) Attributable to Common Shareholders	259	226	267	137	433	532	664	758	985	1,230	2,263
Consolidated Net Income / (Loss)	259	226	267	137	433	532	663	756	978	1,218	2,236
Net Income / (Loss) Continuing Operations	259	226	267	137	433	532	663	756	964	1,215	1,414
Total Pre-Tax Income	272	282	330	383	364	546	638	806	1,103	1,305	1,514
Total Operating Income	249	266	317	348	360	520	620	735	1,149	1,273	1,356
Total Gross Profit	1,601	1,723	1,880	2,071	2,385	2,608	2,891	3,342	3,718	4,287	4,882
Total Revenue	2,057	2,242	2,423	2,725	3,121	3,361	3,685	4,204	4,616	5,318	6,127
Operating Revenue	2,057	2,242	2,423	2,725	3,121	3,361	3,685	4,204	4,616	5,318	6,127
Total Cost of Revenue	457	519	543	654	736	753	795	862	898	1,031	1,245
Operating Cost of Revenue	457	519	543	654	736	753	795	862	898	1,031	1,245
Total Operating Expenses	1,352	1,457	1,562	1,723	2,025	2,088	2,270	2,608	2,569	3,014	3,526
Selling, General & Admin Expense	155	165	166	197	263	229	285	323	314	377	568
Marketing Expense	453	474	502	549	623	633	632	712	643	725	859
Research & Development Expense	719	776	857	909	1,085	1,137	1,279	1,505	1,590	1,850	2,082
Amortization Expense	-	-	-	-	42	-	-	-	12	9.30	16
Restructuring Charge	0.00	15	9.63	37	13	47	36	33	11	53	0.00
Total Other Income / (Expense), net	23	15	12	36	3.32	25	18	71	-45	32	158
Other Income / (Expense), net	23	15	12	36	3.32	25	18	71	-45	32	158
Income Tax Expense	13	56	63	247	-69	13	-25	49	139	90	100
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	-	-	14	2.84	822
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	0.00	0.00	-0.90	-1.16	-6.16	-12	-28
Basic Earnings per Share	$1.67	$1.46	$1.76	$0.91	$2.90	$3.55	$4.40	$4.96	$6.44	$8.08	$14.78
Weighted Average Basic Shares Outstanding	155.05M	154.96M	152.02M	150.46M	149.04M	149.87M	151.14M	152.70M	153.00M	152.15M	153.14M
Diluted Earnings per Share	$1.64	$1.43	$1.73	$0.88	$2.82	$3.45	$4.27	$4.81	$6.29	$7.92	$14.51
Weighted Average Diluted Shares Outstanding	157.71M	158.07M	154.72M	154.87M	153.39M	154.19M	155.71M	157.34M	156.49M	155.20M	155.94M
Weighted Average Basic & Diluted Shares Outstanding	155.20M	154.70M	151.60M	148.71M	149.52M	150.53M	153.03M	153.44M	152.42M	151.99M	154.58M

This table shows Synopsys' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025
Net Income / (Loss) Attributable to Common Shareholders	272	273	336	349	449	292	408	1,114	296	345	243
Consolidated Net Income / (Loss)	269	270	333	346	446	289	405	1,096	297	345	242
Net Income / (Loss) Continuing Operations	269	273	668	5.80	435	296	423	249	297	349	242
Total Pre-Tax Income	279	297	326	404	457	342	392	315	291	396	189
Total Operating Income	256	292	300	425	353	332	360	304	252	376	165
Total Gross Profit	1,077	1,015	1,094	1,102	1,232	1,154	1,235	1,173	1,185	1,286	1,359
Total Revenue	1,361	1,263	1,354	1,340	1,511	1,455	1,526	1,498	1,455	1,604	1,740
Operating Revenue	1,361	1,263	1,354	1,340	1,511	1,455	1,526	1,498	1,455	1,604	1,740
Total Cost of Revenue	284	248	260	238	279	300	291	325	270	318	381
Operating Cost of Revenue	284	248	260	238	279	300	291	325	270	318	381
Total Operating Expenses	821	722	794	677	879	822	875	869	934	909	1,194
Selling, General & Admin Expense	97	85	100	95	131	115	150	165	167	136	281
Marketing Expense	211	181	186	148	219	210	211	175	209	215	259
Research & Development Expense	465	460	484	440	526	493	509	528	553	554	625
Amortization Expense	-	-	2.01	-	3.53	4.56	4.06	-	4.00	4.00	29
Total Other Income / (Expense), net	23	4.21	25	-21	105	9.46	32	11	39	20	24
Interest Expense	-	-	-	-	-	7.07	12	-	-	94	147
Other Income / (Expense), net	23	4.21	25	-21	105	17	44	11	39	114	171
Income Tax Expense	11	24	-6.95	63	23	45	-31	66	-6.29	47	-53
Net Income / (Loss) Discontinued Operations	-	-2.69	1.09	-	12	-7.00	-18	-	0.00	-3.90	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-2.91	-2.96	-3.20	-2.70	-2.91	-3.02	-3.16	-18	1.73	-0.22	-0.23
Basic Earnings per Share	$1.78	$1.79	$2.21	$2.30	$2.95	$1.91	$2.66	$7.26	$1.91	$2.23	$1.51
Weighted Average Basic Shares Outstanding	152.40M	152.19M	152.02M	152.15M	152.31M	152.97M	153.42M	153.14M	154.41M	154.93M	160.17M
Diluted Earnings per Share	$1.75	$1.76	$2.17	$2.24	$2.89	$1.88	$2.61	$7.13	$1.89	$2.21	$1.50
Weighted Average Diluted Shares Outstanding	155.08M	154.73M	154.95M	155.20M	155.33M	155.77M	156.13M	155.94M	156.19M	156.09M	161.68M
Weighted Average Basic & Diluted Shares Outstanding	152.30M	304.32M	304.17M	151.99M	152.54M	153.22M	153.61M	154.58M	154.62M	155.16M	185.75M

This table details how cash moves in and out of Synopsys' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	10/31/2014	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024
Net Change in Cash & Equivalents	-37	-150	140	70	-325	2.74	507	197	-15	21	2,458
Net Cash From Operating Activities	551	495	587	632	424	801	991	1,493	1,739	1,703	1,407
Net Cash From Continuing Operating Activities	551	495	587	632	424	801	991	1,493	1,739	1,703	1,407
Net Income / (Loss) Continuing Operations	259	226	267	137	433	532	663	756	978	1,218	2,236
Consolidated Net Income / (Loss)	259	226	267	137	433	532	663	756	978	1,218	2,236
Depreciation Expense	193	212	207	189	209	202	210	204	228	247	295
Amortization Expense	-	-	-	0.00	0.00	63	61	65	73	82	107
Non-Cash Adjustments To Reconcile Net Income	71	88	99	112	142	162	357	466	555	694	-116
Changes in Operating Assets and Liabilities, net	28	-30	14	195	-360	-158	-300	1.60	-96	-538	-1,115
Net Cash From Investing Activities	-497	-560	-143	-189	-744	-236	-360	-549	-573	-482	1,223
Net Cash From Continuing Investing Activities	-497	-560	-143	-189	-744	-236	-360	-549	-573	-482	1,223
Purchase of Property, Plant & Equipment	-107	-91	-71	-74	-102	-202	-159	-96	-139	-192	-123
Acquisitions	-395	-340	-60	-259	-653	-37	-201	-296	-422	-298	-157
Purchase of Investments	0.00	-239	-170	-155	-3.56	-3.25	-2.76	-169	-104	-132	-138
Divestitures	-	-	-	-	-	-	-	-	0.00	0.00	1,447
Sale and/or Maturity of Investments	7.77	109	158	296	13	6.36	2.15	13	94	139	195
Other Investing Activities, net	-3.49	0.90	0.00	2.10	-	0.00	0.00	-0.80	-1.20	0.00	0.00
Net Cash From Financing Activities	-74	-62	-307	-373	5.14	-562	-141	-749	-1,116	-1,197	-181
Net Cash From Continuing Financing Activities	-74	-62	-307	-373	5.14	-562	-141	-749	-1,116	-1,197	-181
Repayment of Debt	-236	-327	-191	-383	-294	-525	-290	-32	-80	-2.73	-76
Repurchase of Common Equity	-120	-280	-400	-400	-400	-329	-242	-788	-1,100	-1,206	0.00
Issuance of Common Equity	104	110	125	126	124	156	197	211	238	253	232
Other Financing Activities, net	-22	-25	-27	-37	-46	-57	-82	-139	-174	-241	-338
Effect of Exchange Rate Changes	-17	-23	3.41	-	-11	-	17	2.37	-65	-2.98	8.80
Cash Interest Paid	1.90	2.71	3.71	7.10	15	12	5.14	3.37	1.26	1.00	0.81
Cash Income Taxes Paid	41	60	69	103	253	76	71	150	168	98	680

This table details how cash moves in and out of Synopsys' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025
Net Change in Cash & Equivalents	-263	389	142	-247	-320	390	348	2,039	-241	10,466	-11,591
Net Cash From Operating Activities	115	703	560	326	-88	477	455	563	-67	275	671
Net Cash From Continuing Operating Activities	115	703	560	326	-88	477	455	563	-67	275	671
Net Income / (Loss) Continuing Operations	269	270	333	346	446	289	405	1,096	297	345	242
Consolidated Net Income / (Loss)	269	270	333	346	446	289	405	1,096	297	345	242
Depreciation Expense	57	60	63	67	63	61	56	115	48	49	114
Amortization Expense	19	21	22	21	20	25	31	32	23	45	20
Non-Cash Adjustments To Reconcile Net Income	166	170	179	179	155	204	209	-684	222	71	-22
Changes in Operating Assets and Liabilities, net	-396	182	-37	-287	-772	-103	-245	4.52	-658	-235	316
Net Cash From Investing Activities	-36	-91	-54	-301	-54	-112	-54	1,443	-22	76	-16,500
Net Cash From Continuing Investing Activities	-36	-91	-54	-301	-54	-112	-54	1,443	-22	76	-16,500
Purchase of Property, Plant & Equipment	-44	-48	-46	-53	-40	-38	-40	-4.39	-41	-56	-39
Acquisitions	0.00	-41	-10	-246	-68	-72	-17	-	0.00	-	-16,681
Purchase of Investments	-29	-40	-34	-29	-26	-40	-32	-40	-41	-10	-0.72
Divestitures	-	-	-	-	0.00	-	-	-	24	46	72
Sale and/or Maturity of Investments	37	38	36	28	80	39	35	40	36	21	148
Net Cash From Financing Activities	-377	-214	-351	-254	-187	33	-57	30	-142	10,096	4,237
Net Cash From Continuing Financing Activities	-377	-214	-351	-254	-187	33	-57	30	-142	10,096	4,237
Repayment of Debt	-1.29	-0.12	-1.31	-	-49	-7.81	-19	-	-1.29	-	-1.75
Issuance of Debt	-	-	-	-	-	-	-	-	-	-	4,295
Issuance of Common Equity	22	110	32	88	9.48	106	28	89	14	104	20
Other Financing Activities, net	-92	-25	-82	-42	-147	-65	-66	-59	-125	-42	-76
Effect of Exchange Rate Changes	36	-7.97	-13	-18	9.32	-6.90	3.04	3.34	-9.68	18	0.46

This table presents Synopsys' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	10/31/2014	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024
Total Assets	4,775	5,046	5,240	5,396	6,146	6,405	8,030	8,752	9,418	10,333	13,074
Total Current Assets	1,505	1,469	1,717	1,683	1,544	1,739	2,549	2,808	3,013	3,431	6,470
Cash & Equivalents	986	836	977	1,048	723	729	1,236	1,433	1,418	1,434	3,897
Short-Term Investments	0.00	129	141	-	-	-	0.00	148	148	152	154
Accounts Receivable	327	386	439	451	554	554	781	569	796	857	934
Inventories, net	-	-	-	62	122	142	192	229	212	326	362
Prepaid Expenses	54	71	105	73	68	290	308	430	439	548	1,123
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	-	115	0.00
Plant, Property, & Equipment, net	249	263	257	266	309	430	484	472	483	550	563
Total Noncurrent Assets	3,022	3,314	3,266	3,448	4,293	4,237	4,997	5,472	5,922	6,353	6,041
Goodwill	2,256	2,471	2,518	2,707	3,143	3,171	3,365	3,576	3,842	3,346	3,449
Intangible Assets	365	364	267	254	360	279	254	279	386	240	195
Noncurrent Deferred & Refundable Income Taxes	208	274	282	244	404	390	498	613	671	854	1,247
Other Noncurrent Operating Assets	193	205	200	243	385	396	880	1,004	1,023	1,005	1,150
Total Liabilities & Shareholders' Equity	4,775	5,046	5,240	5,396	6,146	6,405	8,030	8,752	9,418	10,333	13,074
Total Liabilities	1,719	1,912	2,045	2,117	2,661	2,316	3,118	3,453	3,859	4,149	4,050
Total Current Liabilities	1,387	1,578	1,715	1,614	2,102	1,752	2,140	2,413	2,774	2,985	2,650
Short-Term Debt	30	205	205	9.92	344	18	27	75	-	-	0.00
Accounts Payable	397	386	401	500	578	506	624	741	809	1,060	1,164
Current Deferred Revenue	928	968	1,086	1,065	1,153	1,212	1,388	1,518	1,911	1,559	1,392
Other Current Liabilities	-	-	-	-	-	0.00	73	80	54	80	95
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	286	0.00
Total Noncurrent Liabilities	333	333	330	503	559	564	978	1,040	1,084	1,163	1,400
Long-Term Debt	45	-	0.00	134	126	120	101	25	21	18	16
Noncurrent Deferred Revenue	129	131	119	116	167	120	130	136	154	151	341
Other Noncurrent Operating Liabilities	159	202	211	252	266	324	747	878	909	961	1,044
Redeemable Noncontrolling Interest	-	-	-	-	-	-	-	0.00	39	31	30
Total Equity & Noncontrolling Interests	3,056	3,134	3,195	3,280	3,485	4,089	4,912	5,299	5,521	6,153	8,993
Total Preferred & Common Equity	3,056	3,134	3,195	3,276	3,479	4,083	4,907	5,295	5,516	6,147	8,991
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,056	3,134	3,195	3,276	3,479	4,083	4,907	5,295	5,516	6,147	8,991
Common Stock	1,616	1,612	1,646	1,624	1,646	1,637	1,655	1,578	1,489	1,278	1,213
Retained Earnings	1,552	1,726	1,948	2,144	2,544	3,164	3,795	4,550	5,534	6,742	8,984
Treasury Stock	-49	-98	-294	-426	-598	-626	-489	-783	-1,273	-1,676	-1,026
Accumulated Other Comprehensive Income / (Loss)	-62	-105	-105	-66	-113	-92	-54	-50	-234	-196	-180
Noncontrolling Interest	-	-	0.00	4.10	5.86	5.86	4.96	3.81	4.80	5.95	2.50

This table presents Synopsys' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025
Total Assets	9,566	9,791	9,923	10,333	10,558	11,012	11,649	13,074	13,041	23,757	48,230
Total Current Assets	3,028	3,161	3,268	3,431	3,408	4,653	5,128	6,470	6,324	16,879	5,596
Cash & Equivalents	1,155	1,545	1,686	1,434	1,119	1,503	1,840	3,897	3,654	14,119	2,526
Short-Term Investments	147	151	148	152	154	157	154	154	155	145	67
Accounts Receivable	1,035	780	667	857	1,064	835	805	934	893	1,002	1,392
Inventories, net	221	256	283	326	383	378	386	362	415	395	382
Prepaid Expenses	470	429	484	548	688	760	915	1,123	1,206	1,218	1,153
Other Current Nonoperating Assets	-	-	-	115	-	1,020	1,028	-	-	-	74
Plant, Property, & Equipment, net	517	546	536	550	567	567	571	563	546	572	700
Total Noncurrent Assets	6,020	6,083	6,119	6,353	6,583	5,792	5,950	6,041	6,171	6,306	41,935
Goodwill	3,865	3,888	3,888	3,346	4,131	3,427	3,444	3,449	3,433	3,461	26,946
Intangible Assets	361	357	337	240	377	277	266	195	181	173	13,080
Noncurrent Deferred & Refundable Income Taxes	719	774	814	854	954	1,005	1,103	1,247	1,393	1,509	97
Other Noncurrent Operating Assets	1,075	1,064	1,081	1,005	1,120	1,083	1,136	1,150	1,164	1,162	1,812
Total Liabilities & Shareholders' Equity	9,566	9,791	9,923	10,333	10,558	11,012	11,649	13,074	13,041	23,757	48,230
Total Liabilities	3,887	3,918	3,923	4,149	3,852	3,823	3,903	4,050	3,736	13,841	20,616
Total Current Liabilities	2,725	2,749	2,730	2,985	2,645	2,508	2,535	2,650	2,359	2,406	3,444
Short-Term Debt	-	-	-	-	-	-	-	-	-	23	22
Accounts Payable	664	702	905	1,060	699	636	757	1,164	939	904	1,283
Current Deferred Revenue	1,995	1,969	1,744	1,559	1,856	1,457	1,357	1,392	1,321	1,375	1,991
Other Current Liabilities	66	78	80	80	89	85	90	95	99	104	127
Other Current Nonoperating Liabilities	-	-	-	286	-	331	331	-	-	-	20
Total Noncurrent Liabilities	1,162	1,169	1,193	1,163	1,207	1,315	1,368	1,400	1,378	11,435	17,172
Long-Term Debt	21	20	18	18	17	17	16	16	14	10,028	14,318
Noncurrent Deferred Revenue	173	191	195	151	190	308	319	341	316	331	383
Other Noncurrent Operating Liabilities	969	958	980	961	1,000	990	1,034	1,044	1,047	489	2,470
Redeemable Noncontrolling Interest	36	36	36	31	31	31	31	30	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,643	5,837	5,964	6,153	6,676	7,158	7,714	8,993	9,305	9,916	27,614
Total Preferred & Common Equity	5,637	5,832	5,959	6,147	6,671	7,153	7,709	8,991	9,305	9,916	27,615
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,637	5,832	5,959	6,147	6,671	7,153	7,709	8,991	9,305	9,916	27,615
Common Stock	1,294	1,332	1,259	1,278	1,185	1,184	1,194	1,213	1,129	1,221	18,552
Retained Earnings	5,806	6,075	6,390	6,742	7,189	7,478	7,884	8,984	9,279	9,624	9,867
Treasury Stock	-1,321	-1,429	-1,543	-1,676	-1,539	-1,322	-1,188	-1,026	-861	-689	-572
Accumulated Other Comprehensive Income / (Loss)	-142	-146	-147	-196	-163	-188	-180	-180	-242	-240	-232
Noncontrolling Interest	5.95	5.09	5.45	5.95	4.59	4.64	4.98	2.50	0.11	-0.11	-0.35

This table displays calculated financial ratios and metrics derived from Synopsys' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	10/31/2014	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.85%	8.98%	8.04%	12.48%	14.54%	7.68%	9.66%	14.08%	9.79%	15.22%	15.22%
EBITDA Growth	0.41%	6.12%	8.74%	6.70%	0.04%	41.41%	12.27%	18.10%	30.82%	16.36%	17.21%
EBIT Growth	-1.28%	3.48%	17.02%	16.25%	-5.10%	50.05%	16.98%	26.22%	36.99%	18.31%	15.96%
NOPAT Growth	6.88%	-9.73%	20.21%	-51.79%	245.91%	18.46%	26.99%	7.02%	45.46%	18.10%	6.85%
Net Income Growth	4.57%	-12.81%	18.10%	-48.82%	216.72%	23.09%	24.62%	14.00%	29.36%	24.50%	83.55%
EPS Growth	3.80%	-12.80%	20.98%	-49.13%	220.45%	22.34%	23.77%	12.65%	30.77%	25.91%	83.21%
Operating Cash Flow Growth	10.92%	-10.13%	18.47%	7.82%	-32.90%	88.62%	23.83%	50.57%	16.50%	-2.05%	-17.39%
Free Cash Flow Firm Growth	-111.46%	60.63%	2,442.96%	-90.99%	-1,461.98%	156.38%	40.33%	100.05%	19.37%	59.40%	-85.17%
Invested Capital Growth	14.68%	10.66%	-3.84%	4.05%	36.03%	8.26%	8.77%	0.36%	5.14%	-2.53%	27.49%
Revenue Q/Q Growth	1.69%	2.19%	1.96%	2.36%	3.26%	1.69%	4.97%	3.11%	-6.75%	1.05%	-5.64%
EBITDA Q/Q Growth	2.09%	-0.20%	3.62%	2.38%	-5.61%	11.95%	7.20%	0.99%	0.58%	14.12%	-1.34%
EBIT Q/Q Growth	1.14%	-2.16%	8.86%	4.69%	-11.59%	17.03%	10.37%	0.94%	0.09%	17.24%	-5.33%
NOPAT Q/Q Growth	3.75%	-3.21%	9.16%	-59.35%	676.85%	-16.37%	7.27%	-1.12%	-5.17%	20.78%	-8.90%
Net Income Q/Q Growth	2.19%	-5.32%	9.40%	-58.53%	644.33%	-14.95%	5.71%	0.61%	-4.82%	19.05%	50.39%
EPS Q/Q Growth	1.86%	-4.67%	9.49%	-58.49%	605.00%	-15.44%	6.22%	0.00%	-4.41%	18.92%	50.83%
Operating Cash Flow Q/Q Growth	-3.24%	-3.97%	-0.80%	5.88%	-10.89%	12.72%	-1.89%	12.72%	1.34%	-3.81%	20.23%
Free Cash Flow Firm Q/Q Growth	-518.57%	-108.82%	124.86%	-44.60%	1.24%	-6.09%	7.98%	4.33%	24.58%	36.85%	-62.08%
Invested Capital Q/Q Growth	-1.38%	6.56%	-1.11%	-7.09%	6.14%	3.04%	3.31%	2.31%	-3.09%	-6.47%	-1.62%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	77.79%	76.86%	77.59%	75.99%	76.42%	77.60%	78.44%	79.50%	80.54%	80.62%	79.68%
EBITDA Margin	22.60%	22.01%	22.15%	21.01%	18.35%	24.10%	24.67%	25.54%	30.44%	30.74%	31.27%
Operating Margin	12.09%	11.88%	13.10%	12.76%	11.54%	15.48%	16.83%	17.48%	24.89%	23.94%	22.13%
EBIT Margin	13.23%	12.56%	13.60%	14.06%	11.65%	16.23%	17.32%	19.16%	23.91%	24.55%	24.71%
Profit (Net Income) Margin	12.59%	10.08%	11.01%	5.01%	13.86%	15.84%	18.00%	17.99%	21.20%	22.91%	36.49%
Tax Burden Percent	95.22%	80.23%	80.97%	35.65%	118.97%	97.59%	103.96%	93.90%	88.67%	93.31%	147.69%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	4.78%	19.77%	19.03%	64.35%	-18.97%	2.41%	-3.96%	6.10%	12.63%	6.91%	6.59%
Return on Invested Capital (ROIC)	11.79%	9.46%	11.04%	5.32%	15.29%	15.09%	17.66%	18.10%	25.63%	29.90%	28.45%
ROIC Less NNEP Spread (ROIC-NNEP)	9.35%	8.01%	9.86%	3.93%	14.61%	9.25%	15.45%	12.97%	27.29%	28.18%	-2.29%
Return on Net Nonoperating Assets (RNNOA)	-2.93%	-2.16%	-2.61%	-1.10%	-2.50%	-1.03%	-2.92%	-3.29%	-7.60%	-9.16%	0.95%
Return on Equity (ROE)	8.87%	7.30%	8.43%	4.22%	12.79%	14.06%	14.74%	14.81%	18.02%	20.75%	29.40%
Cash Return on Invested Capital (CROIC)	-1.88%	-0.66%	14.95%	1.35%	-15.24%	7.16%	9.26%	17.74%	20.62%	32.47%	4.29%
Operating Return on Assets (OROA)	5.96%	5.73%	6.41%	7.20%	6.30%	8.69%	8.84%	9.60%	12.15%	13.22%	12.94%
Return on Assets (ROA)	5.67%	4.60%	5.19%	2.57%	7.49%	8.48%	9.19%	9.01%	10.77%	12.33%	19.10%
Return on Common Equity (ROCE)	8.87%	7.30%	8.43%	4.22%	12.77%	14.04%	14.72%	14.80%	17.94%	20.60%	29.27%
Return on Equity Simple (ROE_SIMPLE)	8.48%	7.21%	8.35%	4.17%	12.43%	13.04%	13.52%	14.28%	17.74%	19.82%	24.87%
Net Operating Profit after Tax (NOPAT)	237	214	257	124	429	508	645	690	1,004	1,185	1,266
NOPAT Margin	11.51%	9.53%	10.61%	4.55%	13.73%	15.11%	17.49%	16.41%	21.74%	22.29%	20.67%
Net Nonoperating Expense Percent (NNEP)	2.44%	1.45%	1.18%	1.39%	0.68%	5.84%	2.21%	5.13%	-1.66%	1.72%	30.74%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	18.11%	19.21%	14.06%
Cost of Revenue to Revenue	22.21%	23.14%	22.41%	24.01%	23.58%	22.40%	21.56%	20.50%	19.46%	19.38%	20.32%
SG&A Expenses to Revenue	7.54%	7.36%	6.85%	7.22%	8.41%	6.82%	7.72%	7.68%	6.79%	7.08%	9.28%
R&D to Revenue	34.93%	34.62%	35.36%	33.35%	34.76%	33.83%	34.71%	35.79%	34.44%	34.79%	33.98%
Operating Expenses to Revenue	65.71%	64.97%	64.49%	63.24%	64.88%	62.12%	61.61%	62.02%	55.66%	56.67%	57.55%
Earnings before Interest and Taxes (EBIT)	272	282	330	383	364	546	638	806	1,103	1,305	1,514
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	465	493	537	573	573	810	909	1,074	1,405	1,635	1,916
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.09	2.49	2.81	3.97	3.82	5.00	6.61	9.60	8.11	11.61	8.78
Price to Tangible Book Value (P/TBV)	14.67	26.06	21.88	41.29	0.00	32.26	25.20	35.28	34.76	27.87	14.76
Price to Revenue (P/Rev)	3.10	3.48	3.71	4.77	4.26	6.07	8.81	12.09	9.69	13.43	12.88
Price to Earnings (P/E)	24.64	34.50	33.64	95.19	30.76	38.32	48.85	67.08	45.43	58.05	34.86
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.06%	2.90%	2.97%	1.05%	3.25%	2.61%	2.05%	1.49%	2.20%	1.72%	2.87%
Enterprise Value to Invested Capital (EV/IC)	2.55	2.96	3.53	5.09	4.04	5.67	8.24	12.92	10.77	17.85	15.01
Enterprise Value to Revenue (EV/Rev)	2.66	3.14	3.33	4.44	4.18	5.90	8.51	11.73	9.37	13.14	12.22
Enterprise Value to EBITDA (EV/EBITDA)	11.77	14.26	15.03	21.13	22.79	24.47	34.48	45.94	30.77	42.74	39.09
Enterprise Value to EBIT (EV/EBIT)	20.12	24.98	24.47	31.58	35.91	36.33	49.13	61.25	39.18	53.52	49.47
Enterprise Value to NOPAT (EV/NOPAT)	23.12	32.90	31.38	97.66	30.46	39.03	48.63	71.50	43.08	58.94	59.14
Enterprise Value to Operating Cash Flow (EV/OCF)	9.94	14.21	13.75	19.13	30.76	24.75	31.63	33.05	24.86	41.02	53.23
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	23.16	385.67	0.00	82.25	92.74	72.94	53.55	54.29	392.40
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.02	0.07	0.06	0.04	0.13	0.03	0.03	0.02	0.00	0.00	0.00
Long-Term Debt to Equity	0.01	0.00	0.00	0.04	0.04	0.03	0.02	0.00	0.00	0.00	0.00
Financial Leverage	-0.31	-0.27	-0.26	-0.28	-0.17	-0.11	-0.19	-0.25	-0.28	-0.33	-0.41
Leverage Ratio	1.56	1.59	1.63	1.64	1.71	1.66	1.60	1.64	1.67	1.68	1.54
Compound Leverage Factor	1.56	1.59	1.63	1.64	1.71	1.66	1.60	1.64	1.67	1.68	1.54
Debt to Total Capital	2.40%	6.14%	6.03%	4.21%	11.87%	3.26%	2.54%	1.85%	0.37%	0.29%	0.17%
Short-Term Debt to Total Capital	0.96%	6.14%	6.03%	0.29%	8.69%	0.42%	0.54%	1.39%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	1.44%	0.00%	0.00%	3.92%	3.17%	2.84%	2.00%	0.46%	0.37%	0.29%	0.17%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.12%	0.15%	0.14%	0.10%	0.07%	0.78%	0.60%	0.36%
Common Equity to Total Capital	97.60%	93.86%	93.97%	95.67%	87.98%	96.60%	97.36%	98.08%	98.85%	99.11%	99.47%
Debt to EBITDA	0.16	0.42	0.38	0.25	0.82	0.17	0.14	0.09	0.01	0.01	0.01
Net Debt to EBITDA	-1.96	-1.54	-1.70	-1.58	-0.44	-0.73	-1.22	-1.38	-1.10	-0.96	-2.11
Long-Term Debt to EBITDA	0.10	0.00	0.00	0.23	0.22	0.15	0.11	0.02	0.01	0.01	0.01
Debt to NOPAT	0.32	0.96	0.80	1.16	1.10	0.27	0.20	0.15	0.02	0.02	0.01
Net Debt to NOPAT	-3.85	-3.55	-3.55	-7.30	-0.59	-1.16	-1.72	-2.15	-1.54	-1.32	-3.19
Long-Term Debt to NOPAT	0.19	0.00	0.00	1.08	0.29	0.24	0.16	0.04	0.02	0.02	0.01
Altman Z-Score	3.33	3.53	3.82	5.00	4.17	6.78	7.69	10.39	8.69	12.22	13.85
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.06%	0.15%	0.15%	0.12%	0.09%	0.44%	0.69%	0.46%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.09	0.93	1.00	1.04	0.73	0.99	1.19	1.16	1.09	1.15	2.44
Quick Ratio	0.95	0.86	0.91	0.93	0.61	0.73	0.94	0.89	0.85	0.82	1.88
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-38	-15	348	31	-427	241	338	676	807	1,287	191
Operating Cash Flow to CapEx	515.33%	546.25%	825.78%	859.89%	423.28%	395.53%	624.40%	1,559.04%	1,250.27%	887.95%	1,142.43%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.45	0.46	0.47	0.51	0.54	0.54	0.51	0.50	0.51	0.54	0.52
Accounts Receivable Turnover	7.06	6.29	5.88	6.12	6.21	6.07	5.52	6.23	6.77	6.44	6.84
Inventory Turnover	0.00	0.00	0.00	0.00	7.99	5.71	4.76	4.09	4.07	3.84	3.62
Fixed Asset Turnover	9.21	8.76	9.32	10.42	10.85	9.10	8.07	8.79	9.66	10.29	11.01
Accounts Payable Turnover	1.21	1.33	1.38	1.45	1.37	1.39	1.41	1.26	1.16	1.10	1.12
Days Sales Outstanding (DSO)	51.69	57.99	62.12	59.61	58.79	60.18	66.09	58.57	53.95	56.72	53.35
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	45.70	63.97	76.67	89.23	89.61	95.16	100.75
Days Payable Outstanding (DPO)	301.70	275.25	264.52	251.44	267.38	262.93	259.53	289.04	315.12	330.94	325.86
Cash Conversion Cycle (CCC)	-250.01	-217.27	-202.41	-191.83	-162.89	-138.79	-116.77	-141.24	-171.55	-179.06	-171.77
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,145	2,374	2,283	2,375	3,231	3,498	3,805	3,818	4,014	3,913	4,988
Invested Capital Turnover	1.02	0.99	1.04	1.17	1.11	1.00	1.01	1.10	1.18	1.34	1.38
Increase / (Decrease) in Invested Capital	275	229	-91	93	856	267	307	14	196	-102	1,076
Enterprise Value (EV)	5,475	7,034	8,064	12,099	13,055	19,816	31,353	49,334	43,233	69,864	74,895
Market Capitalization	6,386	7,794	8,976	12,999	13,303	20,401	32,456	50,811	44,734	71,394	78,898
Book Value per Share	$19.61	$20.10	$21.11	$21.80	$23.41	$27.17	$32.34	$34.72	$36.07	$40.42	$58.53
Tangible Book Value per Share	$2.79	$1.92	$2.71	$2.10	($0.16)	$4.21	$8.49	$9.44	$8.42	$16.84	$34.81
Total Capital	3,131	3,339	3,400	3,424	3,954	4,227	5,040	5,399	5,580	6,202	9,039
Total Debt	75	205	205	144	469	138	128	100	21	18	16
Total Long-Term Debt	45	0.00	0.00	134	126	120	101	25	21	18	16
Net Debt	-911	-760	-912	-904	-254	-591	-1,108	-1,481	-1,545	-1,568	-4,035
Capital Expenditures (CapEx)	107	91	71	74	100	202	159	96	139	192	123
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-838	-869	-910	-970	-938	-725	-799	-1,111	-1,327	-1,140	-231
Debt-free Net Working Capital (DFNWC)	148	95	207	78	-215	4.08	436	470	238	445	3,820
Net Working Capital (NWC)	118	-110	1.99	68	-559	-14	409	395	238	445	3,820
Net Nonoperating Expense (NNE)	-22	-12	-9.84	-13	-3.95	-25	-19	-66	25	-33	-969
Net Nonoperating Obligations (NNO)	-911	-760	-912	-904	-254	-591	-1,108	-1,481	-1,545	-2,271	-4,035
Total Depreciation and Amortization (D&A)	193	212	207	189	209	264	271	268	301	329	402
Debt-free, Cash-free Net Working Capital to Revenue	-40.72%	-38.78%	-37.58%	-35.60%	-30.05%	-21.56%	-21.69%	-26.42%	-28.76%	-21.44%	-3.77%
Debt-free Net Working Capital to Revenue	7.19%	4.26%	8.54%	2.88%	-6.88%	0.12%	11.84%	11.18%	5.16%	8.37%	62.34%
Net Working Capital to Revenue	5.73%	-4.89%	0.08%	2.51%	-17.90%	-0.40%	11.11%	9.39%	5.16%	8.37%	62.34%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.67	$1.46	$1.76	$0.91	$2.90	$3.55	$4.40	$4.96	$6.44	$8.08	$14.78
Adjusted Weighted Average Basic Shares Outstanding	155.05M	154.96M	152.02M	150.46M	149.04M	149.87M	151.14M	152.70M	153.00M	152.15M	153.14M
Adjusted Diluted Earnings per Share	$1.64	$1.43	$1.73	$0.88	$2.82	$3.45	$4.27	$4.81	$6.29	$7.92	$14.51
Adjusted Weighted Average Diluted Shares Outstanding	157.71M	158.07M	154.72M	154.87M	153.39M	154.19M	155.71M	157.34M	156.49M	155.20M	155.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	153.10M	151.45M	150.10M	148.71M	149.52M	150.53M	153.03M	153.44M	152.42M	151.99M	154.58M
Normalized Net Operating Profit after Tax (NOPAT)	237	226	265	269	261	554	459	721	1,013	1,235	1,266
Normalized NOPAT Margin	11.51%	10.07%	10.93%	9.87%	8.37%	16.48%	12.46%	17.16%	21.96%	23.22%	20.67%
Pre Tax Income Margin	13.23%	12.56%	13.60%	14.06%	11.65%	16.23%	17.32%	19.16%	23.91%	24.55%	24.71%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	46.21%	123.93%	149.91%	292.91%	92.48%	61.83%	36.49%	104.19%	112.42%	98.98%	0.00%

This table displays calculated financial ratios and metrics derived from Synopsys' official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	1/31/2023	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.17%	-1.29%	8.55%	63.67%	10.99%	15.20%	12.65%	11.81%	-3.68%	10.28%	14.03%
EBITDA Growth	-12.40%	-7.59%	30.83%	77.28%	51.97%	13.49%	16.56%	-6.06%	-32.97%	34.45%	-4.22%
EBIT Growth	-14.67%	-12.71%	37.74%	101.98%	63.83%	15.15%	20.41%	-21.99%	-36.36%	40.71%	-16.82%
NOPAT Growth	-25.90%	-14.56%	40.98%	156.61%	36.04%	7.12%	26.74%	-33.13%	-23.19%	15.18%	-45.55%
Net Income Growth	-14.27%	-8.15%	51.63%	128.62%	66.11%	7.09%	21.57%	216.20%	-33.35%	19.38%	-40.16%
EPS Growth	-12.06%	-6.88%	51.75%	128.57%	65.14%	6.82%	20.28%	218.30%	-34.60%	17.55%	-42.53%
Operating Cash Flow Growth	-26.32%	-6.27%	27.25%	-17.14%	-176.50%	-32.20%	-18.61%	72.61%	23.16%	-42.22%	47.33%
Free Cash Flow Firm Growth	-104.88%	-109.71%	237.65%	917.75%	-8,224.84%	-2,437.24%	-287.77%	-281.35%	127.54%	-197.10%	-6,725.80%
Invested Capital Growth	6.15%	7.24%	0.99%	-2.53%	23.94%	15.69%	21.20%	27.49%	1.09%	29.52%	675.22%
Revenue Q/Q Growth	6.00%	-7.24%	7.26%	-1.10%	12.80%	-11.79%	4.88%	-1.84%	-2.83%	10.24%	8.44%
EBITDA Q/Q Growth	22.79%	6.07%	8.97%	19.70%	9.84%	-21.89%	11.91%	-3.52%	-21.63%	61.52%	-19.64%
EBIT Q/Q Growth	31.63%	6.22%	9.77%	24.12%	13.20%	-26.57%	14.78%	-19.58%	-7.65%	68.50%	-31.54%
NOPAT Q/Q Growth	58.54%	9.16%	14.03%	17.15%	-6.71%	-16.55%	34.92%	-38.19%	7.15%	28.88%	-36.22%
Net Income Q/Q Growth	77.24%	0.49%	23.38%	4.04%	28.78%	-35.21%	40.06%	170.59%	-72.85%	16.04%	-29.80%
EPS Q/Q Growth	78.57%	0.57%	23.30%	3.23%	29.02%	-34.95%	38.83%	173.18%	-73.49%	16.93%	-32.13%
Operating Cash Flow Q/Q Growth	-70.84%	512.58%	-20.40%	-41.73%	-126.92%	642.88%	-4.44%	23.58%	-111.99%	508.22%	143.66%
Free Cash Flow Firm Q/Q Growth	78.94%	-69.53%	1,916.17%	73.53%	-255.81%	47.60%	-34.41%	-67.60%	123.66%	-657.42%	-2,987.99%
Invested Capital Q/Q Growth	9.54%	-4.54%	-0.34%	-6.47%	39.29%	-10.89%	4.41%	-1.62%	10.45%	14.16%	524.92%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	79.11%	80.34%	80.77%	82.25%	81.52%	79.35%	80.95%	78.30%	81.45%	80.16%	78.13%
EBITDA Margin	26.10%	29.85%	30.33%	36.71%	35.74%	29.41%	31.38%	30.84%	24.87%	36.44%	27.01%
Operating Margin	18.80%	23.15%	22.16%	31.72%	23.34%	22.83%	23.61%	20.28%	17.30%	23.46%	9.50%
EBIT Margin	20.51%	23.49%	24.04%	30.17%	30.28%	23.48%	25.69%	21.05%	20.00%	30.58%	19.30%
Profit (Net Income) Margin	19.73%	21.38%	24.59%	25.87%	29.53%	19.87%	26.54%	73.15%	20.44%	21.51%	13.93%
Tax Burden Percent	96.20%	91.02%	102.30%	85.75%	97.54%	84.65%	103.29%	347.56%	102.16%	87.11%	127.98%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	80.77%	56.37%
Effective Tax Rate	3.80%	8.07%	-2.14%	15.49%	5.01%	13.30%	-7.83%	20.97%	-2.16%	11.91%	-27.98%
Return on Invested Capital (ROIC)	21.91%	27.06%	28.61%	35.96%	24.62%	27.64%	35.73%	22.07%	19.59%	23.07%	3.53%
ROIC Less NNEP Spread (ROIC-NNEP)	20.14%	26.99%	27.01%	36.62%	15.85%	27.58%	35.00%	-5.06%	18.00%	22.62%	4.21%
Return on Net Nonoperating Assets (RNNOA)	-4.60%	-7.92%	-7.71%	-11.90%	-3.25%	-8.46%	-11.44%	2.10%	-5.68%	-7.88%	1.07%
Return on Equity (ROE)	17.31%	19.13%	20.90%	24.06%	21.37%	19.18%	24.29%	24.17%	13.91%	15.19%	4.60%
Cash Return on Invested Capital (CROIC)	15.97%	14.97%	22.59%	32.47%	4.52%	14.34%	10.88%	4.29%	20.61%	-3.61%	-149.53%
Operating Return on Assets (OROA)	11.49%	12.75%	13.14%	16.24%	16.45%	14.27%	15.47%	11.02%	10.29%	10.94%	4.15%
Return on Assets (ROA)	11.05%	11.60%	13.44%	13.93%	16.05%	12.08%	15.98%	38.30%	10.52%	7.70%	2.99%
Return on Common Equity (ROCE)	17.24%	18.99%	20.74%	23.90%	21.24%	19.06%	24.16%	24.06%	13.88%	15.16%	4.59%
Return on Equity Simple (ROE_SIMPLE)	16.56%	15.60%	17.17%	0.00%	20.92%	19.78%	19.28%	0.00%	22.43%	21.61%	0.00%
Net Operating Profit after Tax (NOPAT)	246	269	306	359	335	288	388	240	257	332	212
NOPAT Margin	18.09%	21.28%	22.63%	26.80%	22.17%	19.79%	25.46%	16.03%	17.68%	20.67%	12.16%
Net Nonoperating Expense Percent (NNEP)	1.77%	0.07%	1.60%	-0.66%	8.77%	0.06%	0.73%	27.13%	1.59%	0.45%	-0.68%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	5.82%	5.01%	-	-	2.67%	2.76%	1.61%	0.50%
Cost of Revenue to Revenue	20.89%	19.66%	19.23%	17.75%	18.48%	20.65%	19.05%	21.70%	18.55%	19.84%	21.87%
SG&A Expenses to Revenue	7.15%	6.71%	7.36%	7.08%	8.69%	7.89%	9.86%	11.01%	11.48%	8.51%	16.13%
R&D to Revenue	34.18%	36.47%	35.77%	32.82%	34.78%	33.90%	33.35%	35.27%	38.01%	34.53%	35.94%
Operating Expenses to Revenue	60.31%	57.19%	58.62%	50.53%	58.19%	56.52%	57.34%	58.01%	64.14%	56.69%	68.63%
Earnings before Interest and Taxes (EBIT)	279	297	326	404	457	342	392	315	291	491	336
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	355	377	411	492	540	428	479	462	362	585	470
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	9.57	9.70	11.54	11.61	12.16	11.32	11.10	8.78	8.73	7.16	3.56
Price to Tangible Book Value (P/TBV)	38.22	35.65	39.65	27.87	37.52	23.47	21.39	14.76	14.27	11.30	0.00
Price to Revenue (P/Rev)	10.42	10.97	13.06	13.43	14.84	12.80	13.17	12.88	13.38	11.41	15.27
Price to Earnings (P/E)	57.21	61.43	66.47	58.05	57.63	56.73	57.09	34.86	38.50	32.81	49.20
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.75%	1.63%	1.50%	1.72%	1.74%	1.76%	1.75%	2.87%	2.60%	3.05%	2.03%
Enterprise Value to Invested Capital (EV/IC)	11.98	13.08	16.01	17.85	14.66	16.34	16.49	15.01	14.05	10.71	2.80
Enterprise Value to Revenue (EV/Rev)	10.18	10.65	12.73	13.14	14.61	12.55	12.87	12.22	12.75	10.83	17.10
Enterprise Value to EBITDA (EV/EBITDA)	38.55	41.12	46.75	42.74	43.91	42.33	43.04	39.09	44.55	35.67	58.93
Enterprise Value to EBIT (EV/EBIT)	49.35	53.62	60.14	53.52	53.85	51.76	52.28	49.47	57.46	45.22	77.41
Enterprise Value to NOPAT (EV/NOPAT)	56.24	61.67	68.24	58.94	62.65	60.65	60.14	59.14	65.11	54.65	103.97
Enterprise Value to Operating Cash Flow (EV/OCF)	31.03	33.27	37.82	41.02	53.24	62.25	71.44	53.23	54.25	54.93	76.32
Enterprise Value to Free Cash Flow (EV/FCFF)	77.25	90.46	71.22	54.29	358.98	122.18	166.11	392.40	68.55	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.07	0.52
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.07	0.52
Financial Leverage	-0.23	-0.29	-0.29	-0.33	-0.20	-0.31	-0.33	-0.41	-0.32	-0.35	0.26
Leverage Ratio	1.67	1.65	1.65	1.68	1.62	1.59	1.57	1.54	1.47	2.03	1.69
Compound Leverage Factor	1.67	1.65	1.65	1.68	1.62	1.59	1.57	1.54	1.47	1.64	0.95
Debt to Total Capital	0.36%	0.34%	0.30%	0.29%	0.25%	0.24%	0.20%	0.17%	0.15%	51.76%	34.18%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.11%	0.05%
Long-Term Debt to Total Capital	0.36%	0.34%	0.30%	0.29%	0.25%	0.24%	0.20%	0.17%	0.15%	51.65%	34.13%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.74%	0.70%	0.69%	0.60%	0.53%	0.50%	0.46%	0.36%	0.00%	0.00%	0.00%
Common Equity to Total Capital	98.90%	98.96%	99.01%	99.11%	99.22%	99.27%	99.33%	99.47%	99.85%	48.24%	65.82%
Debt to EBITDA	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	5.63	7.68
Net Debt to EBITDA	-0.94	-1.25	-1.27	-0.96	-0.69	-0.88	-1.02	-2.11	-2.18	-1.92	6.29
Long-Term Debt to EBITDA	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	5.62	7.67
Debt to NOPAT	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	8.63	13.55
Net Debt to NOPAT	-1.37	-1.88	-1.85	-1.32	-0.99	-1.26	-1.42	-3.19	-3.19	-2.94	11.10
Long-Term Debt to NOPAT	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	8.61	13.53
Altman Z-Score	9.85	10.21	12.12	11.93	14.34	14.56	15.03	13.55	14.94	4.70	3.36
Noncontrolling Interest Sharing Ratio	0.41%	0.76%	0.76%	0.69%	0.63%	0.59%	0.56%	0.46%	0.22%	0.21%	0.10%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.11	1.15	1.20	1.15	1.29	1.86	2.02	2.44	2.68	7.02	1.62
Quick Ratio	0.86	0.90	0.92	0.82	0.88	0.99	1.10	1.88	1.99	6.34	1.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-8.62	-15	265	461	-718	-371	-498	-835	198	-1,102	-34,024
Operating Cash Flow to CapEx	260.06%	1,449.63%	1,213.48%	614.07%	-217.35%	1,242.03%	1,138.27%	12,823.38%	-165.68%	495.37%	1,738.01%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-11.68	-232.25
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.92	4.58
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.33	4.32
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.56	0.54	0.55	0.54	0.54	0.61	0.60	0.52	0.51	0.36	0.21
Accounts Receivable Turnover	4.99	6.86	7.80	6.44	5.21	7.83	8.82	6.84	6.21	6.77	5.86
Inventory Turnover	5.03	4.62	4.28	3.84	3.40	4.16	4.04	3.62	3.10	3.24	3.50
Fixed Asset Turnover	10.40	9.93	10.29	10.29	10.09	11.36	11.73	11.01	10.91	10.93	10.13
Accounts Payable Turnover	1.81	1.65	1.31	1.10	1.51	1.97	1.62	1.12	1.51	1.63	1.32
Days Sales Outstanding (DSO)	73.18	53.19	46.79	56.72	70.08	46.61	41.36	53.35	58.82	53.89	62.32
Days Inventory Outstanding (DIO)	72.56	78.94	85.25	95.16	107.40	87.75	90.45	100.75	117.81	112.53	104.30
Days Payable Outstanding (DPO)	201.44	220.72	278.49	330.94	242.53	185.07	224.84	325.86	241.87	224.04	277.05
Cash Conversion Cycle (CCC)	-55.71	-88.59	-146.45	-179.06	-65.06	-50.70	-93.02	-171.77	-65.24	-57.62	-110.43
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,397	4,198	4,183	3,913	5,450	4,856	5,070	4,988	5,510	6,290	39,306
Invested Capital Turnover	1.21	1.27	1.26	1.34	1.11	1.40	1.40	1.38	1.11	1.12	0.29
Increase / (Decrease) in Invested Capital	255	283	41	-102	1,053	659	887	1,076	60	1,433	34,236
Enterprise Value (EV)	52,678	54,918	66,971	69,864	79,893	79,331	83,601	74,895	77,433	67,346	110,036
Market Capitalization	53,918	56,553	68,746	71,394	81,114	80,938	85,544	78,898	81,228	70,972	98,290
Book Value per Share	$36.98	$38.29	$39.16	$40.42	$43.80	$46.89	$50.32	$58.53	$60.19	$64.13	$177.97
Tangible Book Value per Share	$9.26	$10.42	$11.40	$16.84	$14.20	$22.61	$26.10	$34.81	$36.81	$40.62	($79.99)
Total Capital	5,699	5,893	6,018	6,202	6,724	7,206	7,761	9,039	9,319	20,554	41,954
Total Debt	21	20	18	18	17	17	16	16	14	10,638	14,340
Total Long-Term Debt	21	20	18	18	17	17	16	16	14	10,615	14,318
Net Debt	-1,281	-1,675	-1,816	-1,568	-1,256	-1,643	-1,979	-4,035	-3,795	-3,626	11,746
Capital Expenditures (CapEx)	44	48	46	53	40	38	40	4.39	41	56	39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-999	-1,283	-1,296	-1,140	-510	485	599	-231	156	232	-420
Debt-free Net Working Capital (DFNWC)	303	412	538	445	763	2,145	2,593	3,820	3,965	14,496	2,174
Net Working Capital (NWC)	303	412	538	445	763	2,145	2,593	3,820	3,965	14,473	2,151
Net Nonoperating Expense (NNE)	-22	-1.18	-27	13	-111	-1.20	-16	-856	-40	-14	-31
Net Nonoperating Obligations (NNO)	-1,281	-1,675	-1,816	-2,271	-1,256	-2,332	-2,675	-4,035	-3,795	-3,626	11,692
Total Depreciation and Amortization (D&A)	76	80	85	88	83	86	87	147	71	94	134
Debt-free, Cash-free Net Working Capital to Revenue	-19.30%	-24.89%	-24.63%	-21.44%	-9.33%	7.67%	9.22%	-3.77%	2.56%	3.73%	-6.53%
Debt-free Net Working Capital to Revenue	5.87%	8.00%	10.23%	8.37%	13.96%	33.92%	39.93%	62.34%	65.30%	233.00%	33.78%
Net Working Capital to Revenue	5.87%	8.00%	10.23%	8.37%	13.96%	33.92%	39.93%	62.34%	65.30%	232.63%	33.43%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.78	$1.79	$2.21	$2.30	$2.95	$1.91	$2.66	$7.26	$1.91	$2.23	$1.51
Adjusted Weighted Average Basic Shares Outstanding	152.40M	152.19M	152.02M	152.15M	152.31M	152.97M	153.42M	153.14M	154.41M	154.93M	160.17M
Adjusted Diluted Earnings per Share	$1.75	$1.76	$2.17	$2.24	$2.89	$1.88	$2.61	$7.13	$1.89	$2.21	$1.50
Adjusted Weighted Average Diluted Shares Outstanding	155.08M	154.73M	154.95M	155.20M	155.33M	155.77M	156.13M	155.94M	156.19M	156.09M	161.68M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	152.30M	304.32M	304.17M	151.99M	152.54M	153.22M	153.61M	154.58M	154.62M	155.16M	185.75M
Normalized Net Operating Profit after Tax (NOPAT)	286	264	225	356	335	288	252	240	176	332	116
Normalized NOPAT Margin	20.97%	20.88%	16.64%	26.55%	22.17%	19.79%	16.53%	16.03%	12.11%	20.67%	6.65%
Pre Tax Income Margin	20.51%	23.49%	24.04%	30.17%	30.28%	23.48%	25.69%	21.05%	20.00%	24.70%	10.88%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.20	2.29
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.52	1.44
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.61	2.03
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.93	1.18
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	123.78%	132.53%	122.02%	98.98%	0.00%	42.41%	20.18%	0.00%	0.00%	0.00%	0.00%

Key Financial Trends

Synopsys Inc. (NASDAQ: SNPS) has demonstrated consistent revenue growth and solid profitability over the last several years, based on the quarterly financial data spanning from Q3 2022 through Q3 2025.

Key Positive Highlights:

Operating revenue increased steadily from around $1.25 billion in Q3 2022 to nearly $1.74 billion in Q3 2025, indicating strong top-line growth.
Net income attributable to common shareholders has generally risen over the years, with Q3 2025 net income at approximately $242 million, compared to $220 million in Q3 2022.
Gross profit margins remain strong, with consistent gross profits around 78%-79% of revenue across quarters, demonstrating good cost control on revenue.
The company maintains a healthy balance sheet, with total assets growing substantially mainly due to acquisitions, reaching over $48 billion by Q3 2025.
Strong cash flow from operations in recent quarters, including $671 million in Q3 2025, supports ongoing investment and acquisition activity.
Significant investments in R&D expense, exceeding $600 million in recent quarters, reflects commitment to innovation and product development.
Despite increased debt related to acquisitions, the company has managed long-term debt prudently with manageable interest expenses relative to income.
Issuance of common equity has helped fund acquisitions and capital expenditures without overly diluting shareholders, maintaining steady earnings per share.

Neutral Factors to Monitor:

The company's acquisitions have caused a large increase in goodwill and intangible assets on the balance sheet, approaching $40 billion combined by Q3 2025, which may warrant monitoring for potential impairment risk.
Changes in operating assets and liabilities have fluctuated quarter-to-quarter, impacting short term cash flow volatility.
Effective tax rates have varied but remained moderate, contributing positively to net earnings stability.

Areas of Potential Concern:

The substantial acquisition spending, exemplified by a $16.7 billion outflow in Q3 2025 investing activities, leads to significant cash outflows that may pressure liquidity if not managed carefully.
Long-term debt increased to $14.3 billion by Q3 2025, raising leverage and interest costs; interest expense in some quarters is sizable and could affect net income if rates rise or earnings decline.
Negative net cash flow from investing activities in recent quarters, largely due to acquisitions and capital expenditures, could reduce financial flexibility.
Operating cash flow showed volatility, with Q1 2025 exhibiting negative cash from operations, highlighting the impact of working capital and non-cash adjustments.
Selling, general & administrative and marketing expenses have increased in line with revenue, which may challenge margin expansion if not carefully controlled.

Overall, Synopsys is in a strong growth phase, driven by robust revenue and investment in acquisitions and R&D. While leverage and cash outflows related to acquisitions increase financial risk, strong operating performance and cash flow generation provide a solid foundation. Investors should watch for how Synopsys manages integration risks and debt while sustaining profitability and cash generation.

09/13/25 05:40 AM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About Synopsys' Financials

When does Synopsys' financial year end?

According to the most recent income statement we have on file, Synopsys' fiscal year ends in October. Their fiscal year 2024 ended on October 31, 2024.

How has Synopsys' net income changed over the last 10 years?

Synopsys' net income appears to be on an upward trend, with a most recent value of $2.24 billion in 2024, rising from $259.12 million in 2014. The previous period was $1.22 billion in 2023. See where experts think Synopsys is headed by visiting Synopsys' forecast page.

What is Synopsys' operating income?

Synopsys' total operating income in 2024 was $1.36 billion, based on the following breakdown:

Total Gross Profit: $4.88 billion
Total Operating Expenses: $3.53 billion

How has Synopsys' revenue changed over the last 10 years?

Over the last 10 years, Synopsys' total revenue changed from $2.06 billion in 2014 to $6.13 billion in 2024, a change of 197.8%.

How much debt does Synopsys have?

Synopsys' total liabilities were at $4.05 billion at the end of 2024, a 2.4% decrease from 2023, and a 135.6% increase since 2014.

How much cash does Synopsys have?

In the past 10 years, Synopsys' cash and equivalents has ranged from $723.12 million in 2018 to $3.90 billion in 2024, and is currently $3.90 billion as of their latest financial filing in 2024.

How has Synopsys' book value per share changed over the last 10 years?

Over the last 10 years, Synopsys' book value per share changed from 19.61 in 2014 to 58.53 in 2024, a change of 198.4%.

Related Companies

This page (NASDAQ:SNPS) was last updated on 9/13/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synopsys (SNPS) Financials

Key Financial Trends

Financials Breakdown Chart

Frequently Asked Questions About Synopsys' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synopsys (SNPS) Financials

Annual Income Statements for Synopsys

Quarterly Income Statements for Synopsys

Annual Cash Flow Statements for Synopsys

Quarterly Cash Flow Statements for Synopsys

Annual Balance Sheets for Synopsys

Quarterly Balance Sheets for Synopsys

Annual Metrics And Ratios for Synopsys

Quarterly Metrics And Ratios for Synopsys

Key Financial Trends

Financials Breakdown Chart

Frequently Asked Questions About Synopsys' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools